<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De Filette</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Fiers</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Martens</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Birkett</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ramne</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lowenadler</surname>
    <given-names>B.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2006</year>). 
  <article-title>Improved design and intranasal delivery of an M2e-based human influenza A vaccine</article-title>. 
  <source>Vaccine</source>
  <volume>24</volume>, 
  <fpage>6597</fpage>â€“
  <lpage>6601</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2006.05.082</pub-id>
  <?supplied-pmid 16814430?>
  <pub-id pub-id-type="pmid">16814430</pub-id>
 </mixed-citation>
</ref>
